Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | FAAH | O00519 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.31 |
| ▸ | HPGD | P15428 | 3/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL821284 | 1.00 | TSHR (0.34) | TSHRSMN1; SMN2MAPTFAAHKMT2A | |
| SCHEMBL6436298 | 0.81 | — | — | |
| SCHEMBL11963780 | 0.81 | TSHR (0.35) | TSHRSMN1; SMN2MAPTFAAHKMT2A | |
| SCHEMBL589664 | 0.81 | TSHR (0.35) | TSHRSMN1; SMN2MAPTFAAHKMT2A | |
| SCHEMBL5607925 | 0.79 | ALDH1A1 (0.38) | TSHRSMN1; SMN2MAPTFAAHKMT2A | |
| SCHEMBL12006818 | 0.78 | TSHR (0.31) | TSHRSMN1; SMN2MAPTFAAH | |
| SCHEMBL22818510 | 0.77 | ALDH1A1 (0.30) | TSHRALDH1A1 | |
| SCHEMBL4792311 | 0.77 | HTT (0.32) | KMT2A | |
| SCHEMBL368699 | 0.75 | MAPT (0.35) | TSHRSMN1; SMN2MAPTKMT2AALDH1A1 | |
| SCHEMBL9058790 | 0.75 | ALDH1A1 (0.43) | TSHRSMN1; SMN2MAPTKMT2AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 395 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4395730-A1 | DISSOLVABLE SOLID STRUCTURE COMPRISING FIRST AND SECOND POLYMERIC STRUCTURANTS | The Procter & Gamble Company (US) | 2024-07-10 | — | — | EP | claimed |
| US-11666514-B2 | Fibrous structures containing polymer matrix particles with perfume ingredients | THE PROCTER & GAMBLE COMPANY (US) | 2023-06-06 | — | — | US | claimed |
| WO-2023034763-A1 | DISSOLVABLE SOLID STRUCTURE COMPRISING FIRST AND SECOND POLYMERIC STRUCTURANTS | THE PROCTER & GAMBLE COMPANY (US) | 2023-03-09 | — | — | WO | claimed |
| US-20230060806-A1 | DISSOLVABLE SOLID STRUCTURE COMPRISING FIRST AND SECOND POLYMERIC STRUCTURANTS | THE PROCTER & GAMBLE COMPANY | 2023-03-02 | — | — | US | claimed |
| CN-114599773-A | Fabric care compositions with improved microbial robustness and methods of use thereof | 高露洁-棕榄公司 | 2022-06-07 | — | — | CN | claimed |
| EP-3390483-B1 | ENCAPSULATION | PROCTER & GAMBLE (US) | 2022-05-18 | — | — | EP | claimed |
| CN-107148267-B | Active substance particles with dual taste masking technology, method for the production thereof and orodispersible tablets containing the same | 埃迪制药公司 | 2021-03-12 | — | — | CN | claimed |
| US-20200093710-A1 | FIBROUS STRUCTURES CONTAINING POLYMER MATRIX PARTICLES WITH PERFUME INGREDIENTS | THE PROCTER & GAMBLE COMPANY | 2020-03-26 | — | — | US | claimed |
| EP-0991368-B2 | POLYMERIZABLE ISOLATION BARRIERS AND METHODS FOR FORMING AND USING SUCH BARRIERS | ULTRADENT PRODUCTS INC (US) | 2017-05-10 | — | — | EP | claimed |
| US-9192908-B2 | Encapsulated solid hydrophilic particles | ENCAPSYS, LLC (US) | 2015-11-24 | — | — | US | claimed |
| EP-0906902-B1 | A method for the production of an alkylamino (meth)acrylate and apparatus therefor. | NIPPON CATALYTIC CHEM IND (JP) | 2002-08-28 | — | — | EP | claimed |
| US-6417392-B1 | CATALYTIC ESTER INTERCHANGE OF ALKYL (METH)ACRYLATE AND ALKYLAMINO ALCOHOL; DISTILLATION OF ALKYL ALCOHOL BY-PRODUCT IN AZEOTROPIC MIXTURE WITH ALKYL (METH)ACRYLATE; PURIFICATION USING ION EXCHANGE RESIN | NIPPON SHOKUBAI CO., LTD. (JP) | 2002-07-09 | — | — | US | claimed |
| US-6305936-B1 | UNSATURATED MONOMER, CURING AGENT, WET TISSUE ADHERENCE ACCENTUATOR, REFLECTIVE MATERIAL AND ORGANIC POLYMERIZATION STRENGTH REDUCER; CONFINING DENTAL TREATMENT | ULTRADENT PRODUCTS, INC. | 2001-10-23 | — | — | US | claimed |
| US-6268528-B1 | OXIDIZING DIALKYLNAPHTHALENE TO NAPHTHALENEDICARBOXYLIC ACID IN SOLVENT CONTAINING LOWER ALIPHATIC CARBOXYLIC ACID USING MOLECULAR OXYGEN-CONTAINING GAS IN PRESENCE OF A CATALYST COMPRISING COBALT COMPOUND, MANGANESE COMPOUND AND BROMINE | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2001-07-31 | — | — | US | claimed |
| US-6086370-A | Polymerizable isolation barriers containing reflective materials and methods for forming and using such barriers | ULTRADENT PRODUCTS, INC. (US) | 2000-07-11 | — | — | US | claimed |
| EP-0991368-A1 | POLYMERIZABLE ISOLATION BARRIERS AND METHODS FOR FORMING AND USING SUCH BARRIERS | Ultradent Products, Inc. (US) | 2000-04-12 | — | — | EP | claimed |
| US-6048202-A | THE POLYMERIZABLE ISOLATION BARRIER COMPRISING THE MIXTURE PRODUCTS OF ATLEAST ONE MONOMER, A CURING AGENT FOR CURING THE MONOMER AND A TISSUE ADHERENCE ACCENTUATOR SUCH AS GUM OR CELLULOSE PRODUCT | ULTRADENT PRODUCTS, INC. (US) | 2000-04-11 | — | — | US | claimed |
| EP-0982290-A2 | Method for handling alkylamino (meth)acrylates | Nippon Shokubai Co., Ltd. (JP) | 2000-03-01 | — | — | EP | claimed |
| EP-0906902-A2 | A method for the production of an alkylamino (meth)acrylate and apparatus therefor. | NIPPON SHOKUBAI CO., LTD. (JP) | 1999-04-07 | — | — | EP | claimed |
| WO-1998036700-A1 | POLYMERIZABLE ISOLATION BARRIERS AND METHODS FOR FORMING AND USING SUCH BARRIERS | ULTRADENT PRODUCTS, INC. (US) | 1998-08-27 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11666514-B2 | Fibrous structures containing polymer matrix particles with perfume ingredients | FSCN1, FLNA, PFN1 | TSHR 4800/4885SMN1; SMN2 3790/4885MAPT 61/4885 |
| US-20200093710-A1 | FIBROUS STRUCTURES CONTAINING POLYMER MATRIX PARTICLES WITH PERFUME INGREDIENTS | FSCN1, FLNA, PFN1 | TSHR 4800/4885SMN1; SMN2 3790/4885MAPT 61/4885 |
| US-20230060806-A1 | DISSOLVABLE SOLID STRUCTURE COMPRISING FIRST AND SECOND POLYMERIC STRUCTURANTS | SGMS2, DEGS1, SGMS1 | TSHR 3864/4885SMN1; SMN2 356/4885MAPT 1898/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.